Smoking, Eating, Vaping, Dabbing Are Most Common Routes of Marijuana Use
By Elana Gotkine HealthDay Reporter
WEDNESDAY, April 23, 2025 -- Smoking, eating, vaping, and dabbing are the most common routes of marijuana use, according to research published in the April 10 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Zerleen S. Quader, Ph.D., from the CDC in Atlanta, and colleagues examined the weighted prevalence rates of current and daily or near-daily marijuana use overall and by demographic characteristics, as well as by pregnancy status among women aged 49 years and younger, using data from 22 states and two territories that administered the optional marijuana module of the Behavioral Risk Factor Surveillance System in 2022.
The researchers found among the 15.3 percent of respondents who reported current marijuana use, smoking, eating, vaping, and dabbing (inhaling heated concentrated cannabis) were the most frequent routes (79.4, 41.6, 30.3, and 14.6 percent, respectively). Among persons aged 18 to 24 years, vaping and dabbing were the most prevalent routes of use.
"Messaging can focus on the risks related to each of these routes of use, such as exposure to contaminants or adulterants with vaping, or exposure to high concentrations of tetrahydrocannabinol from ingestion, vaping, and dabbing," the authors write. "These findings can be used to guide tailored educational messaging for cannabis-related harms."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.